TrialBritish journal of cancer2005

Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study.

P F Conte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.